Innovent Biologics, Inc.
IVBXF
Other OTC13.11
USD
+0.27
- -
Total Valuation
Innovent Biologics, Inc. carries a market capitalization of 22.82B, placing it among publicly traded companies globally.
| Market Cap | 22.82B |
| Enterprise Value | N/A |
Stock Price Statistics
Innovent Biologics, Inc.'s stock has declined approximately -3.95604% over the past 52 weeks. The 50-day moving average sits at 12.07, while the 200-day moving average is 11.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -3.95604% |
| 50-Day Moving Average | 12.07 |
| 200-Day Moving Average | 11.01 |
| Average Volume (20 Days) | N/A |